##### 



AMENDED
AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT
  among
  UNITED STATES PHARMACEUTICAL GROUP, L.L.C.
and
NATIONSHEALTH HOLDINGS, L.L.C.
  and
  CAPITALSOURCE
FINANCE LLC/
  Dated as of
June 29, 2004




---



##### 



REVOLVING
CREDIT AGREEMENT
 TABLE
OF CONTENTS
 PageI.
    
    DEFINITIONS
    
    
    11.1
    
    General Terms
    
    
    1II.
    
    ADVANCES, PAYMENT AND INTEREST
    
    
    22.1
    
    The Revolving Facility
    
    
    22.2
    
    The Note; Maturity
    
    
    42.3
    
    Interest
    
    
    52.4
    
    Revolving Facility Disbursements; Requirement to Deliver Borrowing Certificate
    
    
    62.5
    
    Revolving Facility Collections; Repayment; Borrowing Availability and Lockbox
    
    
    62.6
    
    Promise to Pay; Manner of Payment
    
    
    72.7
    
    Repayment of Excess Advances
    
    
    82.8
    
    Payments by Lender
    
    
    82.9
    
    Grant of Security Interest; Collateral
    
    
    82.10
    
    Collateral Administration
    
    
    92.11
    
    Power of Attorney
    
    
    10III.
    
    FEES AND OTHER CHARGES
    
    
    113.1
    
    Commitment Fee
    
    
    113.2
    
    Unused Line Fee
    
    
    113.3
    
    Collateral Management Fee
    
    
    113.4
    
    Computation of Fees; Lawful Limits
    
    
    123.5
    
    Default Rate of Interest
    
    
    123.6
    
    Acknowledgement of Joint and Several Liability
    
    
    12IV.
    
    CONDITIONS PRECEDENT
    
    
    134.1
    
    Conditions to Initial Overadvance on Restatement Date and Closing
    
    
    134.2
    
    Conditions to Each Advance and Overadvance
    
    
    14V.
    
    REPRESENTATIONS AND WARRANTIES
    
    
    155.1
    
    Organization and Authority
    
    
    155.2
    
    Loan Documents
    
    
    155.3
    
    Subsidiaries, Capitalization and Ownership Interests
    
    
    165.4
    
    Properties
    
    
    165.5
    
    Other Agreements
    
    
    175.6
    
    Litigation
    
    
    175.7
    
    Hazardous Materials
    
    
    175.8
    
    Potential Tax Liability; Tax Returns; Governmental Reports
    
    
    185.9
    
    Financial Statements and Reports
    
    
    185.10
    
    Compliance with Law
    
    
    185.11
    
    Intellectual Property
    
    
    195.12
    
    Licenses and Permits; Labor
    
    
    195.13
    
    No Default
    
    
    195.14
    
    Disclosure
    
    
    195.15
    
    Existing Indebtedness; Investments, Guarantees and Certain Contracts
    
    
    205.16
    
    Other Agreements
    
    
    205.17
    
    Insurance
    
    
    20




---



##### 



Page5.18
    
    Names; Location of Offices, Records and Collateral
    
    
    
    
    
    
    
    
    205.19
    
    Non-Subordination
    
    
    
    
    
    
    
    
    205.20
    
    Accounts and Inventory
    
    
    
    
    
    
    
    
    215.21
    
    Healthcare
    
    
    
    
    
    
    
    
    225.22
    
    Survival
    
    
    
    
    
    
    
    
    225.23
    
    Merger Documents, HealthTrans Agreement, Wellpoint Agreement and Employment
Agreements
    
    
    
    
    
    
    
    
    22VI.
    
    AFFIRMATIVE COVENANTS
    
    
    
    
    
    
    
    
    236.1
    
    Financial Statements, Borrowing Certificate, Financial Reports and Other
Information
    
    
    
    
    
    
    
    
    236.2
    
    Payment of Obligations
    
    
    
    
    
    
    
    
    256.3
    
    Conduct of Business and Maintenance of Existence and Assets
    
    
    
    
    
    
    
    
    266.4
    
    Compliance with Legal and Other Obligations
    
    
    
    
    
    
    
    
    266.5
    
    Insurance
    
    
    
    
    
    
    
    
    266.6
    
    True Books
    
    
    
    
    
    
    
    
    276.7
    
    Inspection; Periodic Audits
    
    
    
    
    
    
    
    
    276.8
    
    Further Assurances; Post Closing
    
    
    
    
    
    
    
    
    276.9
    
    Payment of Indebtedness
    
    
    
    
    
    
    
    
    276.10
    
    Lien Searches
    
    
    
    
    
    
    
    
    276.11
    
    Use of Proceeds
    
    
    
    
    
    
    
    
    286.12
    
    Collateral Documents; Security Interest in Collateral
    
    
    
    
    
    
    
    
    286.13
    
    Right of First Refusal
    
    
    
    
    
    
    
    
    286.14
    
    Taxes and Other Charges
    
    
    
    
    
    
    
    
    296.15
    
    Payroll Taxes
    
    
    
    
    
    
    
    
    306.16
    
    Inventory Controls
    
    
    
    
    
    
    
    
    30VII.
    
    NEGATIVE COVENANTS
    
    
    
    
    
    
    
    
    307.1
    
    Financial Covenants
    
    
    
    
    
    
    
    
    307.2
    
    Permitted Indebtedness
    
    
    
    
    
    
    
    
    307.3
    
    Permitted Liens
    
    
    
    
    
    
    
    
    317.4
    
    Investments; New Facilities or Collateral; Subsidiaries
    
    
    
    
    
    
    
    
    327.5
    
    Dividends; Redemptions
    
    
    
    
    
    
    
    
    327.6
    
    Transactions with Affiliates
    
    
    
    
    
    
    
    
    327.7
    
    Charter Documents; Fiscal Year; Name; Jurisdiction of Organization;
Dissolution; Use of Proceeds
    
    
    
    
    
    
    
    
    337.8
    
    Truth of Statements
    
    
    
    
    
    
    
    
    337.9
    
    IRS Form 8821
    
    
    
    
    
    
    
    
    337.10
    
    Transfer of Assets
    
    
    
    
    
    
    
    
    337.11
    
    Payment on Permitted Subordinated Debt
    
    
    
    
    
    
    
    
    347.12
    
    Merger Documents
    
    
    
    
    
    
    
    
    347.13
    
    HealthTrans Agreement and Wellpoint Agreement
    
    
    
    
    
    
    
    
    347.14
    
    NationsHealth Supply L.L.C.
    
    
    
    
    
    
    
    
    34VIII.
    
    EVENTS OF DEFAULT
    
    
    
    
    
    
    
    
    35IX.
    
    RIGHTS AND REMEDIES AFTER DEFAULT
    
    
    
    
    
    
    
    
    379.1
    
    Rights and Remedies
    
    
    
    
    
    
    
    
    379.2
    
    Application of Proceeds
    
    
    
    
    
    
    
    
    389.3
    
    Rights of Lender to Appoint Receiver
    
    
    
    
    
    
    
    
    39




---



##### 



Page9.4
    
    Rights and Remedies not Exclusive
    
    
    39X.
    
    WAIVERS AND JUDICIAL PROCEEDINGS
    
    
    3910.1
    
    Waivers
    
    
    3910.2
    
    Delay; No Waiver of Defaults
    
    
    4010.3
    
    Jury Waiver
    
    
    4010.4
    
    Cooperation in Discovery and Litigation
    
    
    40XI.
    
    EFFECTIVE DATE AND TERMINATION
    
    
    4111.1
    
    Termination and Effective Date Thereof
    
    
    4111.2
    
    Survival
    
    
    41XII.
    
    MISCELLANEOUS
    
    
    4212.1
    
    Governing Law; Jurisdiction; Service of Process; Venue
    
    
    4212.2
    
    Successors and Assigns; Participations; New Lenders
    
    
    4212.3
    
    Application of Payments
    
    
    4312.4
    
    Indemnity
    
    
    4312.5
    
    Notice
    
    
    4312.6
    
    Severability; Captions; Counterparts; Facsimile Signatures
    
    
    4412.7
    
    Expenses
    
    
    4412.8
    
    Entire Agreement
    
    
    4512.9
    
    Lender Approvals
    
    
    4512.10
    
    Publicity
    
    
    4512.11
    
    Release of Lender
    
    
    4512.12
    
    Agent
    
    
    46ANNEX I
    
    
    
    
    1FINANCIAL COVENANTS
    
    
    11)
    
    Minimum EBITDA
    
    
    12)
    
    Fixed Charge Coverage Ratio (EBITDA/Fixed Charges)
    
    
    13)
    
    Cash Velocity
    
    
    24)
    
    Minimum Liquidity and Working Capital
    
    
    2APPENDIX A
    
    
    
    
    1DEFINITIONS
    
    
    
    
    1




---



##### 



AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT
 THIS
AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT Agreement UNITED STATES PHARMACEUTICAL GROUP, L.L.C. d/b/a
NATIONSHEALTH NATIONSHEALTH HOLDINGS, L.L.C., Borrower CAPITALSOURCE FINANCE LLC Lender
 Original
Credit Agreement Revolving
Facility Facility Cap
 Overadvance
Facility Overadvance Facility Cap
   I. DEFINITIONS
 1.1 General Terms
 Appendix A Appendix A Appendix A Appendix A Appendix A




---



##### 



2 II. ADVANCES, PAYMENT AND INTEREST
 2.1 The Revolving Facility
 provided that sum minus Availability provided however Inventory Field Examination
 , Overadvances
 Initial Overadvance Initial Overadvances
 Subsequent Overadvance Subsequent Overadvances




---



##### 



3 Amount of SubsequentTest Period Ending
    
    
    EBITDA
    
    
    OveradvanceJanuary 31, 2005 through
June 30, 2005
    
    
    Less than $6,000,000
    
    
    $
    0.00Greater than or
equal to $6,000,000
but less than
$6,250,000
    
    
    Not to exceed $1,000,000Greater than or
equal to $6,250,000
but less than
$6,500,000
    
    
    Not to exceed $2,000,000Greater than or
equal to $6,500,000
but less than
$7,000,000
    
    
    Not to exceed $3,000,000Greater than or
equal to $7,000,000
but less than
$7,500,000
    
    
    Not to exceed $4,000,000Greater than or
equal to $7,500,000
    
    
    Not to exceed $5,000,000July 31, 2005 through
December 31, 2005
    
    
    Less than $7,500,000
    
    
    $
    0.00Greater than or
equal to $7,500,000
but less than
$7,700,000
    
    
    Not to exceed $1,000,000Greater than or
equal to $7,700,000
but less than
$8,000,000
    
    
    Not to exceed $2,000,000Greater than or
equal to $8,000,000
but less than
$8,250,000
    
    
    Not to exceed $3,000,000Greater than or
equal to $8,250,000
but less than
$8,500,000
    
    
    Not to exceed $4,000,000Greater than or
equal to $8,500,000
    
    
    Not to exceed $5,000,000January 31, 2006
through December 31,
2006
    
    
    Less than $9,000,000
    
    
    $
    0.00Greater than or
equal to $9,000,000
    
    
    Not to exceed $5,000,000January 31, 2007
through December 31,
2007
    
    
    Less than $10,000,000
    
    
    $
    0.00Greater than or
equal to $10,000,000
    
    
    Not to exceed $5,000,000




---



##### 



4  Dilution Items
 2.2 The Notes; Maturity




---



##### 



5  Revolving Facility Maturity Date
 Initial Overadvance Maturity Date Subsequent Overadvance
Maturity Date
 2.3 Interest
 provided however Section 2.6




---



##### 



6 Section 2.5 Section 2.6
 2.4 Revolving Facility Disbursements; Requirement to Deliver Borrowing Certificate
 Borrowing Date Section 4.2 Schedule 2.4 Automatic Advance Minimum Balance
 2.5 Revolving Facility Collections; Repayment; Borrowing Availability and Lockbox
 Lockbox Account Lockbox Bank Lockbox Agreement




---



##### 





7

Concentration Account Section 2.5 Section 2.5 Section 2.5 Section 2.5


2.6 Promise to Pay; Manner of Payment






---



##### 



8 2.7 Repayment of Excess Advances
 Section
2.6
 2.8 Payments by Lender
  2.9 Grant of Security Interest; Collateral
 Collateral
   provided however




---



##### 



9 Section 2.9 provided however
  2.10 Collateral Administration
 Schedule 5.18B




---



##### 



10     2.11 Power of Attorney




---



##### 



11  III. FEES AND OTHER CHARGES;
 3.1 Commitment Fee, Funding Fees and Finance Fees
    3.2 Unused Line Fee
 Unused Line Fee
 3.3 Collateral Management Fee
 Collateral Management Fee




---



##### 



12  3.4 Computation of Fees; Lawful Limits
 Section 3.4
 3.5 Default Rate of Interest
 Default Rate
 3.6 Acknowledgement of Joint and Several Liability




---



##### 



13 IV. CONDITIONS PRECEDENT
 4.1 Conditions to Initial Overadvance on Restatement Date and Closing
     Solvency Certificate




---



##### 



14   Schedule 5.4
 Section 6.5
      4.2 Conditions to Each Advance and Overadvance
  Section 4.2 provided however




---



##### 



15      V. REPRESENTATIONS AND WARRANTIES
  5.1 Organization and Authority
  5.2 Loan Documents




---



##### 



16 Schedule 5.2
 5.3 Subsidiaries, Capitalization and Ownership Interests
 Schedule 5.3 Schedule 5.3 Schedule 5.3 Schedule 5.3 Schedule 5.3
 5.4 Properties
 Schedule 5.4




---



##### 



17 5.5 Other Agreements
 Merger Agreement RGGPLS GRH Selling
Shareholder(s) MAC Millstream Merger Documents Schedule 5.5
 5.6 Litigation
  5.7 Hazardous Materials




---



##### 



18 5.8 Potential Tax Liability; Tax Returns; Governmental Reports
 Schedule 5.8
 Schedule 5.8
 5.9 Financial Statements and Reports
  5.10 Compliance with Law
 HIPAA




---



##### 



19  5.11 Intellectual Property
 Schedule 5.11 Intellectual Property
 5.12 Licenses and Permits; Labor
  5.13 No Default
  5.14 Disclosure




---



##### 



20 5.15 Existing Indebtedness; Investments, Guarantees and Certain Contracts
 Schedule
5.15A Schedule 5.15A Schedule 1.15B
 5.16 Other Agreements
 Schedule 5.5 Schedule 5.16 Schedule 5.23
 5.17 Insurance
 Section 6.5 Schedule 5.17
 5.18 Names; Location of Offices, Records and Collateral
 Schedule 5.18A Schedule 5.18A Schedule
5.18B
 5.19 Non-Subordination




---



##### 



21 5.20 Accounts and Inventory
  Schedule 5.20




---



##### 



22 Schedule 5.20
 5.21 Healthcare
 Section 5.20
 5.22 Survival
  5.23 Merger Documents, HealthTrans Agreement, Wellpoint Agreement and Employment
Agreements




---



##### 



23 Schedule 5.23
   VI. AFFIRMATIVE COVENANTS
  6.1 Financial Statements, Borrowing Certificate, Financial Reports and Other Information
 Financial Reports Section 2.4




---



##### 



24  Other Materials Section 6.1(a)
 Notices




---



##### 



25  Consents
 Operating Budget
 Non-Compliance Fee Section
6.1 Section 6.1
 6.2 Payment of Obligations




---



##### 



26 6.3 Conduct of Business and Maintenance of Existence and Assets
  6.4 Compliance with Legal and Other Obligations
  6.5 Insurance




---



##### 



27  6.6 True Books
  6.7 Inspection; Periodic Audits
  6.8 Further Assurances; Post Closing
 Schedule 6.8
 6.9 Payment of Indebtedness
  6.10 Lien Searches




---



##### 



28 6.11 Use of Proceeds
  6.12 Collateral Documents; Security Interest in Collateral
  6.13 Right of First Refusal
 Credit Party Offer Section 6.13 Option Period Acceptance Notice Transaction provided however Section 6.13 Section 6.13 Section 6.13




---



##### 



29 Section 6.13
 6.14 Taxes and Other Charges
 Section 6.14 Section 6.14




---



##### 



30 6.15 Payroll Taxes
  6.16 Inventory Covenants
 Schedule 5.20 Schedule 5.20
 VII. NEGATIVE COVENANTS
  7.1 Financial Covenants
 Annex I
 7.2 Permitted Indebtedness
 Permitted Indebtedness Schedule 7.2




---



##### 



31 Section 7.3(v) Annex I provided however provided however
 7.3 Permitted Liens
 Permitted Liens Section 7.2(iii) provided Schedule 7.3




---



##### 



32 7.4 Investments; New Facilities or Collateral; Subsidiaries
 Schedule 5.18B Schedule 5.3
 7.5 Dividends; Redemptions
 , provided, however provided, further
 7.6 Transactions with Affiliates
 provided Section
7.5




---



##### 



33 provided
 7.7 Charter Documents; Fiscal Year; Name; Jurisdiction of Organization; Dissolution; Use of
Proceeds
  7.8 Truth of Statements
  7.9 IRS Form 8821
 Section
4.1
 7.10 Transfer of Assets
  provided




---



##### 



34  provided
 provided
  7.11 Payment on Permitted Subordinated Debt
  7.12 Merger Documents
  7.13 HealthTrans Agreement and Wellpoint Agreement
  7.14 NationsHealth Supply L.L.C.




---



##### 



35 VIII. EVENTS OF DEFAULT
    provided Article VI Sections 6.1(c), 6.2, 6.3(i), (ii) and (iii) 6.5, 6.8, 6.9 and 6.11




---



##### 



36




---



##### 



37   Article VIII
    Section 8(d) (g) (h) (i)(iii) provided Section 8(d)
 IX. RIGHTS AND REMEDIES AFTER DEFAULT
 9.1 Rights and Remedies
 Article VIII




---



##### 



38   9.2 Application of Proceeds
 first




---



##### 



39 second third provided fourth provided
 9.3 Rights of Lender to Appoint Receiver
  9.4 Rights and Remedies not Exclusive
  X. WAIVERS AND JUDICIAL PROCEEDINGS
 10.1 Waivers




---



##### 



40  10.2 Delay; No Waiver of Defaults
  10.3 Jury Waiver
  10.4 Cooperation in Discovery and Litigation




---



##### 



41 XI. EFFECTIVE DATE AND TERMINATION
 11.1 Termination and Effective Date Thereof
 Section 11.1 th ; provided, however Termination Date provided that
 Section 11.1 Section 2.5 Revolver Termination
 11.2 Survival
 Sections 3.4, 3.5, 6.13, 10.1, 10.3, 11.1, 11.2, 12.4, 12.7 and 12.10




---



##### 



42 XII. MISCELLANEOUS
 12.1 Governing Law; Jurisdiction; Service of Process; Venue
 Section 12.5
 12.2 Successors and Assigns; Participations; New Lenders
 TRANSFEREE provided that




---



##### 



43 12.3 Application of Payments
  12.4 Indemnity
 Indemnified Persons Section 12.4 Insured Event provided however Section 12.4
 12.5 Notice
 Section 12.5




---



##### 



44 Receipt
 12.6 Severability; Captions; Counterparts; Facsimile Signatures
  12.7 Expenses




---



##### 



45 12.8 Entire Agreement
  12.9 Lender Approvals
  12.10 Publicity
  12.11 Release of Lender
 Releasing Parties Released
Parties




---



##### 



46 12.12 Agent
 CapitalSource




---



##### 



47   UNITED STATES PHARMACEUTICAL
GROUP, L.L.C. d/b/a
NATIONSHEALTHBy:

/s/
Glenn M. Parker, M.D.Name:
    Glenn M. Parker, M.D.Its: Manager Address for Notices:
 th
 NATIONSHEALTH HOLDINGS, L.L.C.By:
    /s/ Glenn M. Parker, M.D.Name:
    Glenn M. Parker, M.D.Its: Preferred Member
Representative Address for Notices:
 th
 CAPITALSOURCE FINANCE LLCBy:

/s/
Shaila Lakhani OkriName:
    Shaila Lakhani OkriIts: Senior Counsel Address for Notices   th




---



##### 



SCHEDULES
 Schedule 2.4 
    
    Borrowers Account(s)Schedule 5.2 
    
    Required ConsentsSchedule 5.3 
    

Capitalization,
Organization Chart (including all subsidiaries, authorized/issued
capitalization, owners, directors, officers, and managers) and Joint
VenturesSchedule 5.4 
    
    Liens; Real and Personal Property Owned or Leased; LeasesSchedule 5.5 
    
    Merger DocumentsSchedule 5.8 
    
    TaxesSchedule 5.11 
    
    Intellectual PropertySchedule 5.15A 
    
    Existing IndebtednessSchedule 5.15B 
    
    Indebtedness Maturing During TermSchedule 5.16 
    
    Other AgreementsSchedule 5.17 
    
    InsuranceSchedule 5.18A 
    
    Corporate NamesSchedule 5.18B 
    
    Places of Business; Collateral LocationSchedule 5.20 
    
    Inventory Sold or Acquired on Approval or Consignment BasisSchedule 5.23 
    
    Healthtrans AgreementSchedule 6.8 
    
    Further Assurances/Post ClosingSchedule 7.2 
    
    Permitted IndebtednessSchedule 7.3 
    
    Permitted Liens




---



##### 



ANNEX I
 FINANCIAL COVENANTS
 1) Minimum EBITDA
  Test Period Ending
    
    
    Minimum EBITDAMay 31, 2004 through July 31, 2004
    
    
    ($3,100,000)August 31, 2004 through September 30, 2004
    
    
    ($2,000,000)October 31, 2004 through December 31, 2004
    
    
    $1,000,000January 31, 2005 through June 30, 2005
    
    
    $4,000,000July 31, 2005 through December 31, 2005
    
    
    $7,000,000January 31, 2006 through December 31, 2006
    
    
    $8,500,000January 31, 2007 and thereafter
    
    
    $9,400,000
 2) Fixed Charge Coverage Ratio (EBITDA/Fixed Charges)
  Calendar Month Ending
    
    
    RatioMay 31, 2004 through July 31, 2004
    
    
    (8.00) to 1.0August 31, 2004 through September 30, 2004
    
    
    (5.00) to 1.0October 31, 2004 through December 31, 2004
    
    
    1.00 to 1.0January 31, 2005 and thereafter
    
    
    1.50 to 1.0




---



##### 



2 3) Cash Velocity
 provided
 Calendar Month Ending
    
    
    Cash VelocityMay 31, 2004
    
    
    $3,800,000June 30, 2004 through July 31, 2004
    
    
    $4,600,000August 31, 2004 through September 30, 2004
    
    
    $7,500,000October 31, 2004 through December 31, 2004
    
    
    $9,000,000January 31, 2005 through June 30, 2005
    
    
    $12,000,000July 31, 2005 through December 31, 2005
    
    
    $14,000,000January 31, 2006 through December 31, 2006
    
    
    $16,000,000January 31, 2007 and thereafter
    
    
    $17,500,000
 4) Minimum Liquidity and Working Capital
  Time Period
    
    
    AmountRestatement Date through May 31, 2004
    
    
    $400,000June 1, 2004 through July 31, 2004
    
    
    $700,000August 1, 2004 through September 30, 2004
    
    
    $900,000October 31, 2004 and all times thereafter
    
    
    $1,500,000
  Available Cash




---



##### 



3 Cash Equivalents S&P Moodys Approved Bank
 EBITDA plus
 Fixed Charge Coverage Ratio
 Fixed Charges
 Interest Expense
 Interest Rate Agreement
 Net Income




---



##### 



4  Test Period
 Total Debt Service




---



##### 



APPENDIX A
 DEFINITIONS
 Acceptance Notice Section 6.13
 Accounts
 Account Debtor
 Advance
 Affiliate
 Applicable Rate
 Availability Section 2.1(a)
 Borrowing Base provided however
 Borrowing Certificate Exhibit A-1 Exhibit A-2




---



##### 



2 Borrowing Date Section 2.4
 Business Day
 Capital Expenditures
 Capital Lease
 Capitalized Lease Obligations
 Change of Control . Merger
 Charter and Good Standing Documents




---



##### 



3  Closing
 Closing Date
 Collateral Section 2.9
 Collateral Patent, Trademark and Copyright Assignment
 Collateral Management Fee Section
3.3
 Concentration Account Section 2.5
 Credit Party Section 6.13
 Debtor Relief Law
 Default
 Dilution Items Section 2.1(b)
 Distribution
 Eligible Billed Receivables




---



##### 



4 provided




---



##### 



5




---



##### 



6 Eligible Deductible Unbilled Receivables
 Eligible Inventory




---



##### 



7             Eligible Nondeductible Unbilled Receivables
 Eligible Receivables




---



##### 



8 Eligible Unbilled Receivables
 Employee(s)
 Employee Subordination Agreement
 Employment Agreement
 Enterprise Value
 Environmental Laws
 Equity Participation Fee Agreement
 ERISA
 Event of Default Article
VIII
 Facility Cap
 Fair Valuation
 Finance Fee Payment Date Section
3.1(c)
 GAAP




---



##### 



9 Government Account
 Government Contract
 Governmental Authority
 Guarantor
 Guaranty
 Hazardous Substances
 Healthcare Laws
 HealthTrans
 HealthTrans Agreement
 HeathTrans Triparty Agreement
 Indebtedness




---



##### 



10  Indemnified Person Section 12.4
 Initial Overadvance Section 2.1
 Initial Overadvance Maturity Date
 Insured Event Section 12.4
 Insurer
 Inventory
 Landlord Waiver and Consent
 Liability Event
 Lien
 Loan Loans




---



##### 



11 Loan Documents ,
 Lockbox Accounts Section 2.5
 Lockbox Agreement Section 2.5
 Lockbox Bank Section 2.5
 MAC Section 5.5
 Management or Service Fee
 Material Adverse Effect Material Adverse Change
 Medicaid/Medicare Account Debtor
 Merger
 Merger Agreement Section 5.5
 Merger Documents Section 5.5
 Millstream Section 5.5
 Minimum Termination Fee




---



##### 



12  Note
 Obligations
 Offer Section 6.13
 Option Period Section 6.13
 Original Credit Agreement
 Overadvance Facility
 Overadvance Facility Cap
 Overadvances
 Overadvance Note
 Payment Office
 Permit
 Permitted Discretion
 Permitted Indebtedness Section
7.2
 Permitted Liens Section 7.3




---



##### 



13 Permitted Subordinated Debt
 Person
 Prime Rate provided provided
 Receipt Section 12.5
 Released Parties Section 12.11
 Releasing Parties Section 12.11
 Restatement Date
 Revolver Termination Section
11.1(b)
 Revolving Facility Maturity Date Section 2.2(b)
 Revolving Note
 Security Documents
 Selling Shareholder(s) Section
5.5
 Services
 Solvency Certificate Section
4.1(d)
 Subordination Agreement




---



##### 



14 Subsequent Overadvance Subsequent Overadvances
 Subsequent Overadvance Maturity Date
 Subsidiary
 Tax Distributions
 Term
 Termination Date Section 11.1
 Transferee Section 12.2
 Transaction Section 6.13
 UCC
 Unused Line Fee Section 3.2
 Validity Certificate Exhibit B
 Warehouse Waiver and Consent
 Wellpoint
 Wellpoint Agreement